Reduction of mortality with antithrombin III in septicemic rats : a study of Klebsiella pneumoniae induced sepsisDICKNEITE, G; PAQUES, E.-P.Thrombosis and haemostasis. 1993, Vol 69, Num 2, pp 98-102, issn 0340-6245Article

Comparative study on the in vitro effectiveness of antithrombotic agentsPAQUES, E.-P; ROMISCH, J.Thrombosis research. 1991, Vol 64, Num 1, pp 11-21, issn 0049-3848Article

Annexins : calcium-binding proteins of multi-functional importance?RÖMISCH, J; PAQUES, E.-P.Medical microbiology and immunology. 1991, Vol 180, Num 3, pp 109-126, issn 0300-8584Article

The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranesHUBER, R; ROÊMISCH, J; PAQUES, E.-P et al.EMBO journal (Print). 1990, Vol 9, Num 12, pp 3867-3874, issn 0261-4189, 8 p.Article

Study on the mechanism of action of heparin and related substances on the fibrinolytic system: relationsship between plasminogen activators and heparinPAQUES, E.-P; STÖHR, H.-A; HEIMBURGER, N et al.Thrombosis research. 1986, Vol 42, Num 6, pp 797-807, issn 0049-3848Article

Coagulation and fibrinolysis in cancerHEIMBURGER, N; PAQUES, E.-P; RÖMISCH, J et al.Behring-Institute-Mitteilungen. 1992, Num 91, pp 169-182, issn 0301-0457Article

Annexins I to VI : quantitative determination in different human cell types and in plasma after myocardial infractionRÖMISCH, J; SCHÜLER, E; BASTIAN, B et al.Blood coagulation & fibrinolysis. 1992, Vol 3, Num 1, pp 11-17, issn 0957-5235Article

Variants of human tissue-type plasminogen activator substituted at the protease cleavage site and glycosylation sites, and truncated at the N- and C-terminiHAIGWOOD, N. L; MULLENBACH, G. T; MOORE, G. K et al.Protein engineering (Print). 1989, Vol 2, Num 8, pp 611-620, issn 0269-2139Article

Inhibition of human skin phospholipase A₂ by lipocortins is an indirect effect of substrate/lipocortin interactionBASTIAN, B. C; SELLERT, C; SEEKAMP, A et al.Journal of investigative dermatology. 1993, Vol 101, Num 3, pp 359-363, issn 0022-202XConference Paper

Anticoagulant properties of placenta protein 4 (annexin V)ROÊMISCH, J; SCHORLEMMER, U; FICKENSCHER, K et al.Thrombosis research. 1990, Vol 60, Num 5, pp 355-366, issn 0049-3848, 12 p.Article

Comparison of in vitro and in vivo properties of rHirudin (HBW 023) and a synthetic analogous peptideRÖMISCH, J; DIEHL, K.-H; HOFFMANN, D et al.Haemostasis. 1993, Vol 23, Num 5, pp 249-258, issn 0301-0147Article

In-vivo antithrombotic potency of placenta protein 4 (annexin V)RÖMISCH, J; SEIFFGE, D; REINER, G et al.Thrombosis research. 1991, Vol 61, Num 2, pp 93-104, issn 0049-3848Article

The calcium binding sites in human annexin V by crystal structure analysis at 2.0 Å resolution : implications for membrane binding and calcium channel activityHUBER, R; SCHNEIDER, M; MAYR, I et al.FEBS letters. 1990, Vol 275, Num 1-2, pp 15-21, issn 0014-5793, 7 p.Article

Lipokortine und Phospholipasen : neue Aspekte in der Physiologie der GlukokortikosteroidwirkungBASTIAN, B. C; ROMISCH, J; PAQUES, E.-P et al.Hautarzt. 1991, Vol 42, Num 7, pp 417-423, issn 0017-8470Article

Hämostase, Fibrinolyse, Proteolyse : Wechsselwirkungen mit EntzündungsreaktionenRÖMISCH, J; SCHÜLER, E; PAQUES, E.-P et al.Behring-Institute-Mitteilungen. 1990, Num 86, pp 129-145, issn 0301-0457Article

Carbohydrate structures of a human tissue plasminogen activator variant expressed in recombinant Chinese hamster ovary cellNIMTZ, M; NOLL, G; PAQUES, E.-P et al.FEBS letters. 1990, Vol 271, Num 1-2, pp 14-18, issn 0014-5793Article

Detection of human anti-annexin autoantibodies by enzyme immunoassaysKRAUS, M; RÖMISCH, J; BASTIAN, B et al.Journal of immunoassay. 1992, Vol 13, Num 3, pp 411-439, issn 0197-1522Article

Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma: identification as a multimeric form of S protein (vitronectin)DECLERCK, P. J; DE MOL, M; ALESSI, M. C et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 30, pp 15454-15641, issn 0021-9258Article